Search
Search Results
-
Dupilumab Treatment in Children Aged 6–11 Years With Atopic Dermatitis: A Multicentre, Real-Life Study
BackgroundThe management of paediatric atopic dermatitis (AD) is challenging, mostly relying on emollients and topical corticosteroids. Dupilumab, a...
-
Lichen Planus: What is New in Diagnosis and Treatment?
Lichen planus (LP), an idiopathic, multifaceted chronic inflammatory disease with a heterogeneous clinical presentation, affects approximately 0.5–1%...
-
-
Okuläre Nebenwirkungen von Dupilumab – Übersichtsarbeit und Therapieempfehlung der „Kommission für Trockenes Auge und Oberflächenerkrankungen“ der Österreichischen Ophthalmologischen Gesellschaft (ÖOG)
Dupilumab (Dupixent®, Sanofi and Regeneron Pharmaceuticals) is a human monoclonal antibody against the interleukin (IL)-4 receptor alpha subunit of...
-
-
-
Clinical music interventions and music therapy in dermatology
Music interventions in medicine have been shown to reduce anxiety and depression, decrease pain, and improve quality of life; however, a review of...
-
-
-
Compression Therapy in Dermatology
Purpose of ReviewThe compression therapy provides valuable support during management of vascular and inflammatory lower leg skin disorders. The...
-
Targeted Systemic Therapies for Adults with Atopic Dermatitis: Selecting from Biologics and JAK Inhibitors
Therapeutic options for people with moderate or severe atopic dermatitis refractory to topical therapy have rapidly expanded in recent years. These...
-
-
Facial tinea incognito: a clinical, dermoscopic and mycological study of 38 cases
BackgroundTinea incognito (TI) is a dermatophytic infection of the skin that is modified by steroid use. As a result, it shows atypical clinical...
-
Satisfaction with Control of Mild to Moderate Atopic Dermatitis with Ruxolitinib Cream: US Physician and Patient Perspectives
IntroductionThe 2021 US approval of ruxolitinib cream for treatment of atopic dermatitis (AD) in patients aged ≥ 12 years was based on the results of...
-
A comparative study on a biodegradable hyaluronic acid microneedle patch with a needleless patch for dry skin in atopic dermatitis: a single-blinded, split-body, randomized controlled trial
To overcome interruption of skin barrier in transdermal drug delivery, the microneedle (MN) patch penetrates the barrier by punching with its MNs....
-
Management von bullösem Pemphigoid und Schleimhautpemphigoid
BackgroundBullous pemphigoid (BP) is the most common blistering autoimmune dermatosis and, as an age-associated disease, is also the bullous...
-
Reasons for inpatient dermatological consultation requested by other specialities: a five-year data analysis of 1,052 patients from a Portuguese tertiary teaching hospital
BackgroundThe involvement of a dermatologist in inpatient care can result in accurate diagnosis and prescription of appropriate treatment more...
-
Biomarkers in Atopic Dermatitis
Atopic dermatitis (AD) is a chronic inflammatory skin condition. The pathogenesis involves genetic, environmental, and immunological factors as well...
-
